Jing Yang

Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial

Mary O’Brien, Luis Paz‐Ares, Sandrine Marréaud et al. · The Lancet Oncology · 2022 · 696 citations

Interim Analysis, Surgical Oncology, Oncology +8

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

Jonathan Spicer, Marina Chiara Garassino, Heather A. Wakelee et al. · The Lancet · 2024 · 173 citations · Full text

Oncology, Adjuvant Pembrolizumab, Clinical Trials +8

Oxalate-curcumin–based probe for micro- and macroimaging of reactive oxygen species in Alzheimer’s disease

Jian Yang, Xueli Zhang, Peng Yuan et al. · Proceedings of the National Academy of Sciences · 2017 · 134 citations · Full text

Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo

Jing Yang, Wei Yin, Richard Van et al. · Nature Communications · 2020 · 115 citations · Full text

Tuning the stereo-hindrance of a curcumin scaffold for the selective imaging of the soluble forms of amyloid beta species

Yuyan Li, Jian Yang, Hongwu Liu et al. · Chemical Science · 2017 · 99 citations · Full text